ML083220037
| ML083220037 | |
| Person / Time | |
|---|---|
| Site: | Sequoyah  |
| Issue date: | 11/17/2008 |
| From: | Kennedy K Division of Reactor Safety II |
| To: | Campbell W Tennessee Valley Authority |
| References | |
| Download: ML083220037 (6) | |
Text
UNITED STATES NUCLEAR REGULATORY COMMISSION REGION II SAM NUNN ATLANTA FEDERAL CENTER 61 FORSYTH STREET, SW, SUITE 23T85 ATLANTA, GEORGIA 30303-8931 November 17, 2008 Mr. William R. Campbell, Jr.
Chief Nuclear Officer and Executive Vice President Tennessee Valley Authority 3R Lookout Place 1101 Market Street Chattanooga, TN 37402-2801
SUBJECT:
LICENSED OPERATOR POSITIVE DRUG TEST
Dear Mr. Campbell:
On November 7, 2008, your facility reported that an NRC-licensed operator tested positive for marijuana following a fitness-for-duty test taken on November 7, 2008. This letter is a request for information pertaining to this occurrence. Within 30 days from the date of this letter, please provide answers to the questions listed in the enclosure to this letter and other records and information on this operator's past fitness for duty which are relevant to this occurrence. Any other information that you think is pertinent or useful regarding this occurrence also would be appreciated. We request that any personal privacy, proprietary, or safeguards information in your response be provided in a separate attachment and appropriately marked. The affidavit required by 10 CFR 2.390(b) must accompany your response, where applicable.
You should determine whether the operator meets the requirements of 10 CFR 55.33(a) (1).
You should ensure that (1) the operator meets the general health requirements of ANSI/ANS-3.4-1983, (2) the operator does not have a disqualifying condition under Section 5.3 of that standard, and (3) documentation describing the designated physician's conclusion that the operator meets the requirements of ANSI/ANS-3.4-1983 is available for review by the NRC.
If a conditional license is requested per 10 CFR 55.25, that condition should be documented on NRC Form 396 and transmitted to the NRC.
If you determine that the operator no longer meets the medical qualifications described in 10 CFR 55.33(a)(1) then, in accordance with 10 CFR 55.25, you should notify the NRC via letter of the operator's incapacitation. For example, you must notify the NRC if you determine based on your employee assistance program in consultation with your designated physician, that the operator can no longer meet the medical criteria of ANSI/ANS-3.4-1983.
The NRC will evaluate the information in your reply to this letter to determine if further action is warranted pursuant to 10 CFR Parts 50 or 55. The information supplied will be maintained in NRC Privacy System of Records-16 and will be subject to the Privacy Act.
TVA 2
In accordance with 10 CFR 2.390 of the NRCs Rules of Practice, a copy of this letter and its enclosures will be available electronically for public inspection in the NRC Public Document Room or from the Publicly Available Records (PARS) component of the NRCs document system (ADAMS). ADAMS is accessible from the NRC website at http://www.nrc.gov/reading-rm.adams.html (the Public Electronic Reading Room).
Sincerely,
/RA/
Kriss M. Kennedy, Director Division of Reactor Safety Docket Nos.: 50-327, 50-328 License Nos.: DPR-77, DPR-79
Enclosure:
Licensed Operator Fitness-For-Duty Questionnaire cc w/encl: 55-Docket File Timothy P. Cleary Site Vice President Sequoyah Nuclear Plant Tennessee Valley Authority Electronic Mail Distribution Christopher R. Church Plant Manager Sequoyah Nuclear Plant Tennessee Valley Authority Electronic Mail Distribution James D. Smith Manager, Licensing and Industry Affairs Sequoyah Nuclear Plant Tennessee Valley Authority Electronic Mail Distribution
November 17, 2008 Mr. William R. Campbell, Jr.
Chief Nuclear Officer and Executive Vice President Tennessee Valley Authority 3R Lookout Place 1101 Market Street Chattanooga, TN 37402-2801
SUBJECT:
LICENSED OPERATOR POSITIVE DRUG TEST
Dear Mr. Campbell:
On November 7, 2008, your facility reported that an NRC-licensed operator tested positive for marijuana following a fitness-for-duty test taken on November 7, 2008. This letter is a request for information pertaining to this occurrence. Within 30 days from the date of this letter, please provide answers to the questions listed in the enclosure to this letter and other records and information on this operator's past fitness for duty which are relevant to this occurrence. Any other information that you think is pertinent or useful regarding this occurrence also would be appreciated. We request that any personal privacy, proprietary, or safeguards information in your response be provided in a separate attachment and appropriately marked. The affidavit required by 10 CFR 2.390(b) must accompany your response, where applicable.
You should determine whether the operator meets the requirements of 10 CFR 55.33(a) (1).
You should ensure that (1) the operator meets the general health requirements of ANSI/ANS-3.4-1983, (2) the operator does not have a disqualifying condition under Section 5.3 of that standard, and (3) documentation describing the designated physician's conclusion that the operator meets the requirements of ANSI/ANS-3.4-1983 is available for review by the NRC. If a conditional license is requested per 10 CFR 55.25, that condition should be documented on NRC Form 396 and transmitted to the NRC.
If you determine that the operator no longer meets the medical qualifications described in 10 CFR 55.33(a)(1) then, in accordance with 10 CFR 55.25, you should notify the NRC via letter of the operator's incapacitation. For example, you must notify the NRC if you determine based on your employee assistance program in consultation with your designated physician, that the operator can no longer meet the medical criteria of ANSI/ANS-3.4-1983.
The NRC will evaluate the information in your reply to this letter to determine if further action is warranted pursuant to 10 CFR Parts 50 or 55. The information supplied will be maintained in NRC Privacy System of Records-16 and will be subject to the Privacy Act.
xG SUNSI REVIEW COMPLETE OFFICE RII:DRS RII:DRS RII:DRS RII:DRS RII:DRS RII:DRP SIGNATURE NAME RBaldwin MWidmann MErnstes RCroteau KKennedy EGuthrie DATE 11/14/2008 11/14/2008 11/14/2008 11/17/2008 11/14/2008 11/14/2008 11/ /2008 E-MAIL COPY?
YES NO YES NO YES NO YES NO YES NO YES NO YES NO
TVA 3
Letter to William R. Campbell, Jr. from Kriss M. Kennedy dated November 17, 2008
SUBJECT:
LICENSED OPERATOR POSITIVE DRUG TEST Distribution w/encl:
N. Salagado, IOLB, NRR B. Moroney, NRR (PM: SEQ)
M.Widmann, DRS B. Michael, DRS R. Baldwin, DRS
Enclosure LICENSED OPERATOR FITNESS-FOR-DUTY QUESTIONNAIRE Sequoyah Nuclear Plant is requested to provide the following information concerning the fitness-for-duty report of November 7, 2008, regarding the involved licensed operator:
- 1.
Name and responsibilities of the operator.
- 2.
A summary of the operator's entire fitness-for-duty testing history. Please include the dates and times the operator was tested, the reasons for the tests (i.e., random, for-cause, or follow-up), the results of the tests, the facility cut-off level for the substance involved, and the dates that any tests were confirmed positive.
- 3.
Whether the operator used, sold, or possessed illegal drugs. If so, please provide the details of the circumstances surrounding such use, sale, or possession.
- 4.
Whether the operator was at the controls while under the influence of drugs. If so, please provide the details of the operator's performance of licensed duties while under the influence of drugs, including the time between when the sample was taken and the positive test confirmation.
- 5.
Whether the operator was involved in procedural errors related to this occurrence. If so, please provide the details of the procedural errors and the consequences of the errors.
- 6.
Your intentions with regard to the operator's resumption of duties under the 10 CFR Part 50 and Part 55 licenses, including your plans for follow-up testing.
- 7.
Your company=s policy/procedure on the influence of drugs in the work place. Please include your company=s cut-off limit if it is more stringent than the limit set forth in 10 CFR 26, App. A (2.7) (e) (1).